世界の希少難病治療薬(Orphan Drugs)市場動向(2014~2018)...市場調査レポートについてご紹介

【英文タイトル】Global Orphan Drugs Market 2014-2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Global Biologics Orphan Drugs Market
Market Size and Forecast
06.4 Global Non-Biologic Orphan Drugs Market
Market Size and Forecast
06.5 Five Forces Analysis
07. Market Segmentation by Product
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2012
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Novartis AG
17.1.1 Business Overview
17.1.2 Business Segmentation
17.1.3 Key Information
17.1.4 SWOT Analysis
17.2 F. Hoffmann La Roche Ltd.
17.2.1 Business Overview
17.2.2 Business Segmentation
17.2.3 Key Information
17.2.4 SWOT Analysis
17.3 Celgene Corp.
17.3.1 Business Overview
17.3.2 Key Information
17.3.3 SWOT Analysis
17.4 Pfizer Inc.
17.4.1 Business Overview
17.4.2 Key Information
17.4.3 SWOT Analysis
17.5 Sanofi S.A.
17.5.1 Business Overview
17.5.2 Business Segmentation
17.5.3 Key Information
17.5.4 SWOT Analysis
18. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Orphan Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Biologics Orphan Drugs Market 2013-2018 (US$ billion)
Exhibit 4: Global Non-Biologic Orphan Drugs Market 2013-2018 (US$ billion)
Exhibit 5: Global Orphan Drugs Market Segmentation 2013-2018 (by percentage)
Exhibit 6: Global Orphan Drugs Market Segmentation by Product
Exhibit 7: Global Orphan Drugs Market Segmentation 2013
Exhibit 8: Global Orphan Drugs Market by Geographical Segmentation 2013
Exhibit 9: FDA Approval Time: Orphan vs. Non-Orphan (months)
Exhibit 10: Phase Three Trial Length (yrs) Orphan vs. Non-Orphan
Exhibit 11: Global Orphan Drugs Market by Vendor Segmentation 2013
Exhibit 12: Global Orphan Drugs Market by Vendor Segmentation 2018
Exhibit 13: Global Orphan Drug Sales: Top 20 companies 2013-2018
Exhibit 14: Global USA and EU Orphan Designations per year (2009-2012)
Exhibit 15: Business Segmentation of Novartis AG
Exhibit 16: Business Segmentation of F. Hoffmann La Roche Ltd.
Exhibit 17: Business Segmentation of Sanofi S.A.


【レポート販売概要】

■ タイトル:世界の希少難病治療薬(Orphan Drugs)市場動向(2014~2018)
■ 英文:Global Orphan Drugs Market 2014-2018
■ 発行日:2014年1月17日
■ 調査会社:Technavio
■ 商品コード:IRTNTR3181
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。